Clinical Registration Study of Patients with the Delta Variant of COVID-19 Based on Multi-parameters Cardiac Magnetic Resonance

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100048877

Enrollment

Unknown

Registered

2021-07-19

Start date

2021-07-16

Completion date

Unknown

Last updated

2022-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Delta Variant of Novel Coronavirus Pneumonia (COVID-19)

Interventions

case group:Nil

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. All patients with the conditions to diagnose the Delta variant of COVID-19. Signed an informed consent form to participate in the study.

Exclusion criteria

Exclusion criteria: 1. CMR examination routine contraindications (such as pacemaker/ICD implantation/claustrophobia/renal insufficiency/MR contrast agent hypersensitivity) .

Design outcomes

Primary

Measure	Time frame
New onset arrhythmias, re-hospitalization of heart failure, cardiogenic death, all-cause death;Cardiac magnetic resonance, echocardiography, ventricular morphology, function, strain, extracellular volume, etc, ECG indicators, and myocardial binomial, blood routine and biochemical examinations;	—

Contacts

Public ContactLiu Jinxin

Guangzhou Eighth People's Hospital, Guangzhou Medical University

Liujx83710378@126.com+86 13802538153

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026